9FZ-17469-34264
2 vaccinations
3 coded responses
8 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 275 / NC
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Pfizer-BioNTech
-
2021-01-22
Registered in v-safe
-
2021-01-22
Survey response — days 1–6 daily, dose 1MedDRA: Immediate post-injection reaction, Injection site pain, Injection site paraesthesia, Medical counselling, Paraesthesia, Self-medication — Feeling: Fair · Site: Pain, Swelling · Be unable to work, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Systemic reaction (other): 35 to 65 minutes after the injection, I had tingling under the skin grow slowly from the injection site, to my elbow, to my shoulder, to my neck, to my wrist, to my ear, and down my leg eventually to my foot, on the left side of my body, same said as the injection. I was in touch with my office HCP who administered the vaxn and she recommended I take Benadryl, which I took 500 mg at 75 min after injection, and later that evening the tingling had gone away. I felt okay the day after, only mild pain at injection site. · Healthcare visit (other): I mentioned that yesterday, the day of the vaccine, I was in touch with the HCP who administered the vaccine ((b)(6) office)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-22
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-01-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Headache, Muscle or body aches, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-01-27
- 2021-02-03
-
2021-02-12
Dose 2 — Pfizer-BioNTech
-
2021-02-12
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache · Be unable to workAdult check-in
- 2021-02-21
- 2021-05-28
-
2021-08-15
Survey response — 6 months, dose 2MedDRA: Chest pain — Feeling: Good · Be unable to work or attend schoolFree text: Chest painMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-12
Survey response — 12 months, dose 2MedDRA: Blepharospasm, Chest discomfort, Fatigue, Headache, Nasal congestion, Vertigo — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Vertigo, fatigue, headache, nasal congestion, eyelid spasm, chest tightnessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-12
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Pfizer-BioNTech | |
| 2 | 2021-02-12 | Pfizer-BioNTech |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): 35 to 65 minutes after the injection, I had tingling under the skin grow slowly from the injection site, to my elbow, to my shoulder, to my neck, to my wrist, to my ear, and down my leg eventually to my foot, on the left side of my body, same said as the injection. I was in touch with my office HCP who administered the vaxn and she recommended I take Benadryl, which I took 500 mg at 75 min after injection, and later that evening the tingling had gone away. I felt okay the day after, only mild pain at injection site.
Healthcare visit (other): I mentioned that yesterday, the day of the vaccine, I was in touch with the HCP who administered the vaccine ((b)(6) office)
redacted (b)(6)
Release 9 — 6 months, dose 2
Symptoms: Chest pain
Release 11 — 12 months, dose 2
Symptoms: Vertigo, fatigue, headache, nasal congestion, eyelid spasm, chest tightness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Blepharospasm | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Chest pain | ✓ | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Vertigo | · | · | ✓ |
| SRO | Immediate post-injection reaction | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site paraesthesia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Self-medication | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release